CLINICAL_TRIALS
trial_result
· 2014-08-07
Clinical Trial Update: Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia [Phase 4]
Summary
Phase 4 trial evaluating weekly dosing of D-cycloserine for cognitive function in individuals with schizophrenia has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-08-07